<h1>NCLT Proceedings Update: Max Healthcare Institute and Kalinga Hospital matter listed for August 19</h1>
The legal dispute involving Max Healthcare Institute Limited, its subsidiary Kalinga Hospital Ltd. (KHL), and BRS Capital Two Pte. Limited has been reviewed by the National Company Law Tribunal (NCLT). The company received an order from the Hon'ble NCLT on August 7, 2026, regarding petitions filed before the Cuttack Bench concerning KHL.
The matter involves interlocutory petitions raised by BRS Capital Two Pte. Limited against Kalinga Hospital Ltd., a subsidiary of the Company, and Max Healthcare Institute Limited. These proceedings were heard by the NCLT on August 4, 2026.
During the hearing, both the Company and other Respondents objected to the maintainability of the interlocutory petition, citing an incorrect Postal Ballot Notice annexed with the application. The Hon'ble NCLT observed that this specific issue was procedural in nature. To ensure justice consistent with principles of natural justice, the Tribunal permitted the opposing party to rectify the defect by filing an additional affidavit.
The case has since been scheduled for further consideration on August 19, 2026, and will be heard alongside the main Company Petition. No developments regarding litigation against key management personnel or settlement of the proceedings were noted at this time.
Key updates concerning the ongoing legal matter are detailed below:
| Particulars | Details |
|---|---|
| Date of Hearing | August 4, 2026 |
| Tribunal Observation | The NCLT noted a procedural defect (incorrect Postal Ballot Notice). |
| Rectification Process | The opposite party was permitted to rectify the defect by filing an additional affidavit. |
| Next Listing Date | August 19, 2026 |
MAXHEALTH Stock Price Movement
Shares of Max Healthcare Institute Limited slipped on Friday, settling at ₹1070 after the stock shed ₹2.40, representing a 0.22% decline. The equity traded with a volume of 1.19 million shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.